Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

10.39
BATS BZX Real-Time Price
As of 9:52am ET
 +0.11 / +1.07%
Today’s Change
5.69
Today|||52-Week Range
13.84
-8.05%
Year-to-Date
No recent news for Merrimack Pharmaceuticals Inc.

Today’s Trading

Previous close10.28
Today’s open10.39
Day’s range10.24 - 10.39
Volume24,728
Average volume (3 months)1,193,321
Market cap$1.1B
Dividend yield--
Data as of 9:37am ET, 08/04/2015

Growth & Valuation

Earnings growth (last year)+39.39%
Earnings growth (this year)-40.62%
Earnings growth (next 5 years)+5.61%
Revenue growth (last year)+115.03%
P/E ratioNM
Price/Sales11.48
Price/Book--

Competitors

 Today’s
change
Today’s
% change
HRTXHeron Therapeutics I...+0.25+0.76%
RPTPRaptor Pharmaceutica...+0.06+0.41%
RGENRepligen Corp+0.17+0.48%
ZFGNZafgen Inc+0.29+0.78%
Data as of 9:52am ET, 08/04/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)-$0.30
Annual revenue (last year)$102.8M
Annual profit (last year)-$83.3M
Net profit margin-81.06%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert J. Mulroy
Head-
Corporate Operations
William M. McClements
Corporate headquarters
Cambridge, Massachusetts

Forecasts